Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBR Study (Bromhexine for Bile Reduction)
jRCTs041250002Not yet recruiting
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bromhexine in obstructive jaundice, hepatobiliary cancer (HBC) and Pancreatic neoplasia. Primary endpoint: Change in bile viscosity. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
bromhexine
03
Conditions
obstructive jaundicehepatobiliary cancer (HBC)Pancreatic neoplasia
Beyond the preview
Go deeper on jRCTs041250002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250002.